ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 138 filers reported holding ACCELERON PHARMA INC in Q2 2016. The put-call ratio across all filers is 6.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $224,000 | -25.8% | 5,146 | -2.5% | 0.00% | -25.0% |
Q3 2018 | $302,000 | +37.3% | 5,278 | +16.3% | 0.00% | +33.3% |
Q2 2018 | $220,000 | +24.3% | 4,537 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $177,000 | -10.6% | 4,537 | -2.7% | 0.00% | 0.0% |
Q4 2017 | $198,000 | -1.5% | 4,662 | -13.3% | 0.00% | 0.0% |
Q3 2017 | $201,000 | +45.7% | 5,376 | +18.4% | 0.00% | +50.0% |
Q2 2017 | $138,000 | +6.2% | 4,539 | -7.3% | 0.00% | 0.0% |
Q1 2017 | $130,000 | -4.4% | 4,897 | -8.0% | 0.00% | -33.3% |
Q4 2016 | $136,000 | -77.1% | 5,320 | -67.6% | 0.00% | -70.0% |
Q3 2016 | $594,000 | +6.6% | 16,400 | 0.0% | 0.01% | -9.1% |
Q2 2016 | $557,000 | +28.6% | 16,400 | 0.0% | 0.01% | +37.5% |
Q1 2016 | $433,000 | -45.9% | 16,400 | 0.0% | 0.01% | -42.9% |
Q4 2015 | $800,000 | +79.8% | 16,400 | -8.2% | 0.01% | +100.0% |
Q3 2015 | $445,000 | -59.8% | 17,860 | -49.0% | 0.01% | -12.5% |
Q2 2015 | $1,108,000 | +177.0% | 35,000 | +233.3% | 0.01% | +33.3% |
Q1 2015 | $400,000 | -2.2% | 10,500 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $409,000 | +31.1% | 10,500 | 0.0% | 0.01% | +20.0% |
Q3 2014 | $312,000 | – | 10,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |